58 filings
Page 3 of 3
8-K
tw8gb
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
pov z8dclb
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
s4h5s 1w9n
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am
8-K
sq2hxl0l06sw0lbtida
31 Aug 20
Entry into a Material Definitive Agreement
9:00am
8-K
60br4001mqlrd 99
5 Aug 20
Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results
8:22am
8-K
scu 8f7xa
20 May 20
Departure of Directors or Certain Officers
4:05pm
8-K
5e1gz
18 May 20
Axcella Announces Pricing of Public Offering of Common Stock
4:17pm
8-K
lw8cl5q
11 May 20
Axcella Reports First Quarter Financial Results and Provides Business Update
8:13am
8-K
1t8xt
8 May 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
dxt2wrom2 zzb
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
8-K
6tm83q
23 Mar 20
Axcella Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:03pm
8-K
5tww9g
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
8-K
nta6 ob9x
12 Nov 19
Results of Operations and Financial Condition
4:04pm
8-K
3w3jv1e9zo rr
8 Nov 19
Departure of Directors or Certain Officers
4:08pm
8-K
jb1q1swi1j99yl94ii
23 Aug 19
Entry into a Material Definitive Agreement
4:18pm
8-K
d490cc7zu09mi2 ghis
12 Aug 19
Results of Operations and Financial Condition
4:50pm
8-K
0g1qyb8
20 Jun 19
Results of Operations and Financial Condition
4:44pm
8-K
40j9a0p7v
17 May 19
Amendments to Articles of Incorporation or Bylaws
4:07pm